rs1800497 — DRD2/ANKK1 TaqIA (Glu713Lys)
Reduces dopamine D2 receptor density in the striatum, affecting reward processing, reinforcement learning, and addiction susceptibility
Details
- Gene
- DRD2/ANKK1
- Chromosome
- 11
- Risk allele
- A
- Protein change
- p.Glu713Lys
- Consequence
- Missense
- Inheritance
- Codominant
- Clinical
- Risk Factor
- Evidence
- Strong
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Category
Brain & Mental HealthThe Reward Gene — Why Some Brains Need More to Feel Satisfied
In 1990, Kenneth Blum and Ernest Noble published a
landmark paper in JAMA11 landmark paper in JAMA
Blum K, Noble EP et al. Allelic association of human
dopamine D2 receptor gene in alcoholism. JAMA, 1990
linking a genetic marker near the dopamine D2 receptor gene to severe alcoholism.
That marker, called TaqIA, became one of the most studied polymorphisms in
behavioral genetics. Over three decades later, we know it affects far more than
alcohol: this single nucleotide change influences how densely your brain populates
its reward circuits with D2 dopamine receptors, shaping everything from how you
learn from mistakes to how vulnerable you are to addictive behaviors.
What makes TaqIA unusual is a case of mistaken genomic identity. For years it
was attributed to the DRD2 gene itself. In 2004,
Neville and colleagues22 Neville and colleagues
Neville MJ, Johnstone EC, Walton RT. Identification and
characterization of ANKK1: a novel kinase gene closely linked to DRD2 on
chromosome band 11q23.1. Hum Mutat, 2004
discovered that the variant actually sits in exon 8 of an adjacent gene called
ANKK1 (ankyrin repeat and kinase domain containing 1), which encodes a
serine/threonine kinase33 serine/threonine kinase
A type of enzyme that modifies proteins by adding
phosphate groups to serine or threonine amino acids, regulating cell signaling
pathways. Despite living in ANKK1's coding region, TaqIA's primary impact
appears to be on D2 receptor expression in the striatum — the brain's reward hub.
The Mechanism
The A allele (historically called A1) causes a glutamic acid-to-lysine substitution
at position 713 of the ANKK1 protein, within its eleventh
ankyrin repeat44 ankyrin repeat
Ankyrin repeats are structural motifs that mediate protein-protein
interactions. They are found in many signaling proteins and help assemble molecular
complexes. While this change doesn't destroy ANKK1's kinase activity, it may
alter its substrate-binding specificity. Through mechanisms still being clarified,
the A1 allele is associated with reduced D2 dopamine receptor density in the
striatum55 striatum
The striatum is a cluster of interconnected nuclei (caudate and putamen)
deep in the brain that serves as the main input hub of the basal ganglia. It is
central to reward processing, habit formation, and motor control.
A 2016 meta-analysis of PET imaging studies66 2016 meta-analysis of PET imaging studies
Smith CT et al. Genetic variation and
dopamine D2 receptor availability: a systematic review and meta-analysis of human
in vivo molecular imaging studies. Transl Psychiatry, 2016
pooling five studies with 194 healthy participants confirmed that A1 carriers have
significantly lower striatal D2 receptor binding (weighted standardized mean
difference -0.57, 95% CI -0.87 to -0.27, p = 0.0002). This variant explains
approximately 7% of the variance in striatal D2 receptor availability.
Fewer D2 receptors means the brain's reward system is less sensitive to dopamine.
To achieve the same subjective sense of reward or satisfaction, A1 carriers may
need more intense or more frequent stimulation — a concept
Blum termed "reward deficiency syndrome"77 Blum termed "reward deficiency syndrome"
Blum K et al. Reward deficiency syndrome:
a biogenetic model for the diagnosis and treatment of impulsive, addictive, and
compulsive behaviors. J Psychoactive Drugs, 2000.
The Evidence
Addiction and substance use. The most replicated finding is the association
with alcohol dependence. A
2013 meta-analysis of 61 studies88 2013 meta-analysis of 61 studies
Wang F et al. A large-scale meta-analysis
of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol
dependence. Hum Genet, 2013
covering 18,730 participants found a significant association (allelic OR 1.19,
genotypic OR 1.24). The effect was consistent in European populations and
remained stable after correction for publication bias. Associations with smoking
have also been reported, with A1 carriers showing higher smoking rates (pooled
OR 1.50 across multiple studies).
Reward processing and learning. In an influential
fMRI study99 fMRI study
Jocham G et al. Dopamine DRD2 polymorphism alters reversal
learning and associated neural activity. J Neurosci, 2009,
A1 carriers showed impaired reversal learning — they were worse at switching
behavior after feedback changed, and had altered neural responses in the rostral
cingulate zone. A
2008 Science paper by Stice and colleagues1010 2008 Science paper by Stice and colleagues
Stice E et al. Relation between
obesity and blunted striatal response to food is moderated by TaqIA A1 allele.
Science, 2008 demonstrated that
among A1 carriers, higher BMI correlated with progressively blunted striatal
activation during food consumption — suggesting a feed-forward cycle where
reduced reward sensitivity drives compensatory overeating.
ADHD and attention. A
meta-analysis of 11 studies1111 meta-analysis of 11 studies
Pan Y et al. Association between ANKK1 rs1800497
polymorphism of DRD2 gene and ADHD: a meta-analysis. Neurosci Lett, 2015
with 3,286 participants found the A1 allele associated with ADHD risk
(OR 1.79, 95% CI 1.07-2.98 in the dominant model), though the effect was
strongest in African populations and less consistent in European and Asian
samples.
Functional confirmation. A
2023 Biological Psychiatry study1212 2023 Biological Psychiatry study
Montalban E et al. The addiction-susceptibility
TaqIA/Ankk1 controls reward and metabolism through D2 receptor-expressing neurons.
Biol Psychiatry, 2023 using a
mouse model confirmed that ANKK1 is enriched in striatal D2R-expressing neurons,
and that loss of ANKK1 function leads to alterations in learning, impulsivity,
and body metabolism — providing direct causal evidence for the gene's role in
reward circuitry.
Practical Implications
The actionable insight for A1 carriers centers on supporting dopamine production
naturally and being aware of reward-seeking tendencies. The amino acid
L-tyrosine1313 L-tyrosine
The direct biochemical precursor to dopamine. Tyrosine is converted
to L-DOPA by tyrosine hydroxylase, then to dopamine by DOPA decarboxylase
is the rate-limiting precursor for dopamine synthesis. Ensuring adequate tyrosine
intake through protein-rich foods or supplementation may help maintain dopamine
tone. Iron and vitamin D are cofactors in dopamine synthesis pathways — iron is
required by tyrosine hydroxylase, and vitamin D receptors are expressed in
dopamine-producing neurons.
Regular physical exercise is one of the most well-documented ways to upregulate D2 receptor expression naturally. Structured reward environments — breaking large goals into smaller milestones — can help compensate for reduced reward sensitivity. Perhaps most importantly, A1 carriers benefit from understanding their heightened vulnerability to addictive patterns, whether with substances, gambling, or compulsive eating.
Interactions
The COMT gene (rs4680, Val158Met) regulates dopamine breakdown in the prefrontal cortex. Individuals who carry both the ANKK1 A1 allele (reduced D2 receptor density) and COMT Met/Met genotype (slower dopamine clearance) may experience a complex dopamine imbalance: excess prefrontal dopamine coupled with reduced striatal reward sensitivity. Studies of disordered eating have found significant DRD2 x COMT gene-gene interactions affecting eating behavior and body weight regulation. The combined effect may amplify reward-seeking behavior beyond what either variant alone would predict.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Normal dopamine D2 receptor density
The GG genotype means you have the ancestral form of ANKK1 with glutamic acid at position 713. PET imaging studies consistently show that A2/A2 individuals have the highest striatal D2 receptor binding potential. This does not mean you are immune to addiction or reward-related issues — many other genetic and environmental factors contribute — but this particular risk factor does not apply to you.
Moderately reduced D2 receptor density (~20% lower)
Heterozygous A1/A2 carriers show an intermediate reduction in D2 receptor availability. The 2016 PET meta-analysis found a standardized mean difference of -0.57 for all A1 carriers combined (AG and AA) versus GG, explaining about 7% of variance in receptor binding. In practical terms, you may find that routine rewards feel slightly less satisfying and that you need somewhat more stimulation to feel engaged. This is subtle — most heterozygous carriers function well without intervention — but awareness can help you make better choices around habits with addictive potential.
Significantly reduced D2 receptor density (~30-40% lower)
Homozygous A1/A1 carriers have the lowest D2 receptor binding potential in PET imaging studies. The 2008 Science study by Stice et al. showed that among A1 carriers, higher BMI was associated with progressively blunted striatal response to food — suggesting a feed-forward cycle where reduced reward sensitivity drives overconsumption. The Jocham et al. 2009 fMRI study found that A1 carriers had impaired reversal learning, with difficulty switching behavior after feedback changed.
The 2023 mouse model study by Montalban et al. provided causal confirmation: ANKK1 loss of function in D2R-expressing striatal neurons altered learning, impulsivity, and metabolism. While your genotype increases susceptibility to addictive patterns, environmental factors and lifestyle choices have enormous influence on actual outcomes.
Key References
Blum et al. 1990 — landmark JAMA study first reporting association between DRD2 A1 allele and severe alcoholism (N=70 brain samples)
Neville et al. 2004 — discovered that TaqIA resides in ANKK1, not DRD2; the Glu713Lys substitution lies in the 11th ankyrin repeat
Smith et al. 2016 — meta-analysis of 5 PET studies (N=194) confirming A1 carriers have significantly lower striatal D2 binding (SMD -0.57, p=0.0002)
Wang et al. 2013 — meta-analysis of 61 studies (N=18,730) confirming association between TaqIA and alcohol dependence (OR 1.23)
Stice et al. 2008 — Science study showing A1 carriers have blunted striatal response to food reward, linking TaqIA to obesity risk via reward circuitry
Jocham et al. 2009 — fMRI study showing A1 carriers have impaired reversal learning and altered feedback processing in the striatum
Montalban et al. 2023 — Biological Psychiatry study using mouse model showing ANKK1 controls reward and metabolism through D2R-expressing neurons
Pan et al. 2015 — meta-analysis of 11 studies (N=3,286) showing TaqIA association with ADHD (OR 1.79 in dominant model)